Main Article Content

Abstract

RÉSUMÉ
Introduction. La bronchopneumopathie chronique obstructive (BPCO) est l’une des maladies respiratoires chroniques non transmissibles les plus fréquentes. L’objectif était de comparer la prévalence de la BPCO entre les différents niveaux socio-économiques (NSE). Méthodes. Une étude transversale incluant les adultes âgés d’au moins 19 ans par échantillonnage stratifié à trois niveaux dans la ville de Yaoundé était réalisée. La spirométrie était effectuée chez tous les participants. La BPCO a été défini par un trouble ventilatoire obstructif non réversible. Les différents degrés du NSE ont été évalués par l’indice de richesse proposé par la banque mondiale pour le Cameroun. Le NSE bas appartenant au 1er-2e quintile, NSE intermédiaire au 3e-4e quintile et NSE élevé au 5e quintile. Résultats. Des 1229 sujets [âge médian (interquartile range) de 30 (24 - 42) ans, 678 (53,4%) hommes] ayant réalisé la spirométrie, ont été respectivement inclus dans le groupe des pauvres, des sujets à revenus intermédiaires et le groupe des riches, 497 (40,5%) sujets, 498 (40,5%) sujets et 234 (19,0%) sujets. La prévalence (IC à 95%) de la BPCO était plus élevée dans le groupe NSE élevé 5,1% (3,0 - 8,7%) comparé au NSE intermédiaire 3,0% (1,5 - 4,5%) et NSE bas 2,2% (0,9 - 3,4%), (p=0,085). Dans le NSE élevé, les facteurs protecteurs indépendants associés à la survenue de BPCO étaient le niveau d’éducation secondaire et la vie de couple; et les femmes avaient deux fois plus de risque de développer la BPCO. Conclusion. La prévalence de la BPCO est similaire dans les différents NSE à Yaoundé, malgré une tendance d’association entre la BPCO et les riches.
ABSTRACT
Background. Chronic Obstructive Pulmonary Disease (COPD) is a frequent non-communicable respiratory disease. The aim of our study was to compare the prevalence of COPD between socioeconomic status (SES) and look for the independent association between COPD and SES. Materials and methods. Data from a cross-sectional community-based study was analysed. Participants aged 19 years and above were selected through multilevel stratified random sampling methods across Yaounde capital city of Cameroon. Participants with inclusion criteria had perform spirometry. COPD was defined by a post-bronchodilatator air flow limitation. The different levels of SES were evaluated through the “richness index” proposed by the World Bank: low SES (1st-2nd quintile), intermediate SES (3rd-4th quintile) and high SES (5th quintile). Results. Of the 1229 subjects [median (interquartile range) age of 30 (24-42) years, 678 (53,4 %) men] performed spirometry, we have included 497 (40,5 %) subjects in the low SES group, 498 (40,5 %) subjects in the intermediate SES group and 234 (19,0 %) subjects in the high SES group. Prevalence (95% CI) of COPD was 2.2% (0.9-3.4%) in low SES, 3.0% (1.5-4.5%) in intermediate SES and 5.1% (3.0-8.7%) in high SES group without any statistical difference between groups (p=0.085) respectively. Independant protective factor associated to COPD in the high SES were secondary education and marital status. Women in the high SES had a double risk of developing COPD. Conclusion. COPD is not associated to SES in Cameroonian milieu, while there was a tendence of association with the high SES.

Article Details

How to Cite
Balkissou, A., Endale, L. M., Mbele-Onana, C., Tcheubo-Kamgang, B., Magne-Fotso, C., Ngo-Nyonga, M., Kolontchang-Yomi, B., Ebouki, E., Amougou, F., & Pefura, E. Y. (2021). La Broncho-Pneumopathie Chronique Obstructive à Yaoundé: Prévalence et Association avec le Niveau Socio-Economique. HEALTH SCIENCES AND DISEASE, 22(7). Retrieved from https://hsd-fmsb.org/index.php/hsd/article/view/2849

References

  1. Finney LJ, Feary JR, Leonardi-Bee J, Gordon SB, Mortimer K. Chronic obstructive pulmonary disease in sub-Saharan Africa: a systematic review [Review article]. Int J Tuberc Lung Dis. 2013;17:583–9. doi:10.5588/ijtld.12.0619.
  2. Kim Y Il. Chronic obstructive pulmonary disease: Respiratory review of 2013. Tuberculosis and Respiratory Diseases. 2014;76:53–8.
  3. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374:733–43. doi:10.1016/S0140-6736(09)61303-9.
  4. Oakes JM, Rossi PH. The measurement of SES in health research: current practice and steps toward a new approach. Soc Sci Med. 2003;56:769–84. http://www.ncbi.nlm.nih.gov/pubmed/12560010. Accessed 21 Apr 2014.
  5. Alaba O, Chola L. Socioeconomic inequalities in adult obesity prevalence in South Africa: a decomposition analysis. Int J Environ Res Public Health. 2014;11:3387–406. doi:10.3390/ijerph110303387.
  6. Boysen F, van der Berg S, von Maltitz M, du Rand G. Using an asset index to assess trends in poverty in seven sub-Saharan African countries. World Dev. 2008;36:1113–1130.
  7. Eisner MD, Blanc PD, Omachi TA, Yelin EH, Sidney S, Katz PP, et al. Socioeconomic status, race and COPD health outcomes. J Epidemiol Community Health. 2011;65:26–34.
  8. Yin P, Zhang M, Li Y, Jiang Y, Zhao W. Prevalence of COPD and its association with socioeconomic status in China: Findings from China Chronic Disease Risk Factor Surveillance 2007. BMC Public Health. 2011;11:586. doi:10.1186/1471-2458-11-586.
  9. Kainu A, Rouhos A, Sovijärvi A, Lindqvist A, Sarna S, Lundbäck B. COPD in Helsinki, Finland: socioeconomic status based on occupation has an important impact on prevalence. Scand J Public Health. 2013;41:570–8. doi:10.1177/1403494813484554.
  10. Pallasaho P, Lindström M, Põlluste J, Loit HM, Sovijärvi A, Lundbäck B. Low socio-economic status is a risk factor for respiratory symptoms: A comparison between Finland, Sweden and Estonia. International Journal of Tuberculosis and Lung Disease. 2004;8:1292–300.
  11. Golec M, Skórska C, Mackiewicz B, Dutkiewicz J, Góra A, Lemieszek M, et al. Relationship between COPD and lower socioeconomic status in farmers from south-eastern Poland (Lublin region). Rural Remote Heal 14. 2014;:25–31.
  12. van Gemert F, van der Molen T, Jones R, Chavannes N. The impact of asthma and COPD in sub-Saharan Africa. Prim Care Respir J. 2011;20:240–8. doi:10.4104/pcrj.2011.00027.
  13. van Gemert F, Chavannes N, Nabadda N, Luzige S, Kirenga B, Eggermont C, et al. Impact of chronic respiratory symptoms in a rural area of sub-Saharan Africa: an in-depth qualitative study in the Masindi district of Uganda. Prim Care Respir J. 2013;22:300–5. doi:10.4104/pcrj.2013.00064.
  14. Adedoyin RA, Erhabor GE, Olajide A, Anifowose OJ. Influence of self-reported socio-economic status on lung function of adult Nigerians. Physiotherapy. 2010;96:191–7. http://www.sciencedirect.com/science/article/pii/S0031940610000167. Accessed 3 Dec 2013.
  15. Eugene Pierre TAGNE KAMDEM. Caractéristiques des tuberculeux pulmonaires atteints de bronchopneumopathie chronique obstructive à la fin du traitement antituberculeux à l’hôpital Jamot de Yaoundé. Faculté de Médecine et des Sciences Biomédicales; 2013. http://www.hsd-fmsb.org/index.php/hsd/thesis/view/63. Accessed 9 May 2021.
  16. Mounguengui D, Kombila U, Nguemou N, Magne C, Ondounba M, Ibinga L, et al. Caractéristiques Cliniques de la Bronchopneumopathie Chronique Obstructive à l’Hôpital d’Instruction des Armées Omar Bongo Ondimba - Libreville. Heal Sci Dis. 2016;17 June:38–40. www.hsd-fmsb.org.
  17. Pefura-Yone EW, Kengne AP, Balkissou AD, Magne-Fotso CG, Ngo-Yonga M, Boulleys-Nana JR, et al. Prevalence of obstructive lung disease in an African country using definitions from different international guidelines: a community based cross-sectional survey. BMC Res Notes. 2016;9:124. doi:10.1186/s13104-015-1731-6.
  18. Banque Mondiale (Cameroun) : Réexaminer les sources de la croissance. La qualité de l’éducation de base, editor. Cahiers économiques du Cameroun. Washington, D. C.; 2014.
  19. Bureau Central des Recensements et des Etudes de Population, Rapport de présentation des résultas définitifs. http://www.statistics-cameroon.org/downloads/Rapport_de_presentation_3_RGPH.pdf (Téléchargé le 25 février 2012).
  20. Chowgule RV, Shetye VM, Parmar JR et al. Prevalence of respiratory symptoms, bronchial hyperreactivity, and asthma in a megacity: results of the European Community Respiratory Health Survey in Mumbai (Bombay). Am J Respir Crit Care Med. 1998;158:547–54.
  21. GOLD - the Global initiative for chronic Obstructive Lung Disease. http://www.goldcopd.org/other-resources-gold-spirometry-guide.html. Accessed 22 Apr 2014.
  22. Brusasco V, Viegi G R. Standardisation des explorations fonctionnelles respiratoires. Eur respir J. 2005;26:319–38.
  23. Pefura Yone E, Kanko-Nguekam N, Kengne A, Balkissou A, Noseda N, Kuaban C. Spitometric Reference Equations for Semi-Urban and Urban Bantu Cameroonians. Open J Respi Dis. 2013;3:164–74.
  24. Kanervisto M, Vasankari T, Laitinen T, Heliövaara M, Jousilahti P, Saarelainen S. Low socioeconomic status is associated with chronic obstructive airway diseases. Respir Med. 2011;105:1140–6. doi:10.1016/j.rmed.2011.03.008.
  25. Lee SJ, Kim SW, Kong KA, Ryu YJ, Lee JH, Chang JH. Risk factors for chronic obstructive pulmonary disease among never-smokers in Korea. Int J Chron Obstruct Pulmon Dis. 2015;10:497–506. doi:10.2147/COPD.S77662.
  26. Trupin L, Earnest G, San Pedro M, Balmes JR, Eisner MD, Yelin E, et al. The occupational burden of chronic obstructive pulmonary disease. Eur Respir J. 2003;22:462–9. http://www.ncbi.nlm.nih.gov/pubmed/14516136. Accessed 27 Jun 2015.
  27. Lamprecht B, McBurnie MA, Vollmer WM, Gudmundsson G, Welte T, Nizankowska-Mogilnicka E, et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest. 2011;139:752–63. doi:10.1378/chest.10-1253.
  28. Huhti E, Takala J, Nuutinen J, Poukkula A. Chronic respiratory disease in rural women. An epidemiological survey at Hankasalmi, Finland. Ann Clin Res. 1978;10:95–101. http://www.ncbi.nlm.nih.gov/pubmed/677807. Accessed 27 Jun 2015.
  29. Zhou Y, Wang C, Yao W, Chen P, Kang J, Huang S, et al. COPD in Chinese nonsmokers. Eur Respir J. 2009;33:509–18. doi:10.1183/09031936.00084408.
  30. Celli BR, Halbert RJ, Nordyke RJ, Schau B. Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey. Am J Med. 2005;118:1364–72. doi:10.1016/j.amjmed.2005.06.041.